Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application ...

Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for ADCETRIS® (brentuximab vedotin) in combination with ...

Here we report a case of a T-cell lymphoma harboring a lentiviral integration ... immunosequencing of peripheral-blood and duodenal-biopsy samples at indicated days after chimeric antigen receptor ...